The exchange and maximal net flux of glucose across the human erythrocyte. II. The effect of two sulphydryl enzyme inhibitors, chlormerodrin and p-chloromercuribenzene sulfonic acid.
D001557:Benzenesulfonates / Q000494:pharmacology*; D001693:Biological Transport, Active; D001786:Blood Glucose / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002462:Cell Membrane / Q000378:metabolism; D002717:Chlormerodrin / Q000494:pharmacology*; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology; D007457:Iodine Radioisotopes; D007700:Kinetics; D008628:Mercury; D008629:Mercury Isotopes; D008954:Models, Biological; D009942:Organometallic Compounds / Q000494:pharmacology*; D011868:Radioisotopes; D011955:Receptors, Drug / Q000187:drug effects
D001557:Benzenesulfonates; D001786:Blood Glucose; D002250:Carbon Radioisotopes; D007328:Insulin; D007457:Iodine Radioisotopes; D008629:Mercury Isotopes; D009942:Organometallic Compounds; D011868:Radioisotopes; D011955:Receptors, Drug; D002717:Chlormerodrin; D008628:Mercury